^○Norio FURUKORI (Department of Psychiatry, Dokkyo Medical School, School of Medicine, Japan)

^○Ryota HASHIMOTO (Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan)

^○Ken INADA (Dept. of Psychiatry, Tokyo Women's Medical University, Tokyo, Japan)

^○Norio FURUKORI (Department of Psychiatry, Dokkyo Medical School, School of Medicine, Japan)

^○Hiroyoshi TAKEUCHI¹, Tetsufumi KANAZAWA², Koki ITO³, Kazuto OYA⁴ (1. Department of Neuropsychiatry, Keio University School of Medicine, 2. Department of Neuropsychiatry, Osaka Medical College, 3. Department of Psychiatry, Hokkaido University School of Medicine, 4. Department of Psychiatry, Fujita Health University School of Medicine)

^○Aran TAJIKA¹, Seiichiro TARUTANI², Hikaru HORI ³, Yuki MATSUDA⁴, Atsunobu MURATA⁵, Taishiro KISHIMOTO⁶ (1. Department of Psychiatry, Kyoto University Hospital, 2. Shin-Abuyama Hospital, Osaka Institute of Clinical Psychiatry, 3. Department of Psychiatry, School of Medicine, University of Occupational and Environemental Health, 4. Department of Psychiatry Jikei University School of Medicine, 5. Kyowa Hospital Pharmacy, 6. Department of Neuropsychiatry, Keio University School of Medicine)

^○Yoshiteru TAKEKITA¹, Shunichiro IKEDA¹, Shusuke NUMATA², Enami SAWAYAMA³, Hiroshi KIMURA^{4, 5}, Ikuo NOMURA^{6, 7}, Taro SUWA⁸ (1. Department of Neuropsychiatry, Kansai Medical University, 2. Department of Psychiatry,Graduate School of Biomedical Science, Tokushima University, 3. Department of Psychiatry, Kitasato University School of Medicine, 4. Department of psychiatry, Gakuji-Kai Kimura Hospital, 5. Department of psychiatry, Graduate School of Medicine, Chiba University, 6. Department of Psychiatry, Fujita Health University School of Medicine, 7. Department of Psychiatry, Moriyama Integrated Mental Care Hospital, 8. Department of Psychiatry, Graduate School of Medicine, Kyoto University )

^○Itaru MIURA (Department of Neuropsychiatry, Fukushima Medical University School of Medicine, Fukushima, Japan)

^○Takashi TSUBOI¹, Masakazu HATANO², Tsutomu NAGAI³, Tsuyoshi SASAKI⁴, Haruhiko ODA⁵, Satoru ESUMI⁶, Hiroki YAMADA⁷, Hiroshi KADOTANI⁸, Yasuhiko HASHIMOTO⁹, Tetsu TOMITA¹⁰ (1. Department of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan, 2. Department of Clinical Pharmacy, Fujita Health University School of Medicine, Aichi, Japan, 3. Department of Hospital Pharmaceutics, School of Pharmacy, Showa University, Tokyo, Japan, 4. Department of Child Psychiatry, Chiba-University Hospital, Chiba, Japan, 5. Hyogo Mental Health Center, Hyogo, Japan, 6. Department of Pharmacy, Okayama University Hospital, Okayama, Japan, 7. Department of Psychiatry, School of Medicine, Showa University, Tokyo, Japan, 8. Department of Sleep and Behavioral Sciences, Shiga University of Medical Science, Shiga, Japan, 9. Factly of clinical pharmacy, KobeGakuin university, Hyogo, Japan, 10. Department of Neuropsychiatry, Graduate School of Medicine, Hirosaki University, Aomori, Japan)

^○Yoshikazu TAKAESU (Department of Neuropsychiatry, Kyorin University, School of Medicine)

^○Omi WATANABE¹, Kiyotaka NEMOTO², Takaaki YASUDA³, Saya KIKUCHI⁴, Masanobu ITO⁵, Toshihito SUZUKI⁶ (1. Office of Pharmacovigilance I, Pharmaceuticals and Medical Devices Agency, 2. Department of Psychiatry, Faculty of Medicine, University of Tsukuba, 3. Department of Psychiatry, Saitama Medical Center, Saitama Medical University, 4. Department of Psychiatry, Tohoku University Hospital, 5. Department of Psychiatry, Juntendo University Faculty of Medicine, 6. Department of Psychiatry, Juntendo Koshigaya Hospital, Juntendo University School of Medicine)